Dashboard
Manage Tickers

ABBVAbbVie Inc.

NYSE abbvie.com


$ 169.34 $ 0.85 (0.5 %)    

Friday, 07-Jun-2024 15:59:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 462.76 $ -0.41 (-0.09 %)
DIA $ 388.38 $ -0.84 (-0.22 %)
SPY $ 533.54 $ -0.65 (-0.12 %)
TLT $ 91.51 $ -1.71 (-1.83 %)
GLD $ 211.60 $ -7.83 (-3.57 %)
$ 169.42
$ 169.13
$ 0.00 x 0
$ 0.00 x 0
$ 167.80 - $ 170.34
$ 125.85 - $ 181.20
3,745,467
na
300.38B
$ 0.64
$ 50.12
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-20-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-17-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-18-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-02-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-19-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-05-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-07-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-20-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

goldman-sachs-optimistic-about-regenxbios-gene-therapy-pipeline-sees-over-160-upside
Goldman Sachs Optimistic About Regenxbio's...
06/07/2024 18:30:54

Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
06/07/2024 17:35:20

abbvies-arthritis-drug-humira-retains-market-dominance-despite-biosimilar-competition-challenges-biosimilar-industry-viability
AbbVie's Arthritis Drug Humira Retains Mar...
06/07/2024 14:39:05

Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the b...

abbvie-amazon-goldman-sachs-and-2-major-health-care-stocks-on-cnbcs-final-trades
AbbVie, Amazon, Goldman Sachs And 2 Major ...
06/07/2024 12:59:56

AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners.

abbvies-immunogen-acquired-elahere-meets-primary-goal-in-mid-stage-study-in-heavily-pretreated-ovarian-cancer-patients
AbbVie's Immunogen Acquired Elahere Meets ...
06/06/2024 17:02:45

AbbVie announced Phase 2 PICCOLO trial results for Elahere in heavily pre-treated ovarian cancer patients. The trial achieved a...

Core News & Articles
CNBC Halftime Report Final Trades: Amazon....
06/06/2024 17:01:50

abbvie-announces-topline-results-from-phase-2-piccolo-trial-evaluating-mirvetuximab-soravtansine-for-high-folate-receptor-alpha-expressing-platinum-sensitive-ovarian-cancer-piccolo-met-its-primary-endpoint-with-an-orr-of-519-the-median-dor-a-key-secondary-endpoint-was-825-months
AbbVie Announces Topline Results From Phas...
06/06/2024 12:47:18

PICCOLO trial met its primary endpoint of objective response rate (ORR)Data from the study will be presented at a future medica...

abbvie-treats-first-patient-with-investigational-abbv-383-in-phase-3-cervino-study-for-relapsedrefractory-multiple-myeloma
AbbVie Treats First Patient With Investiga...
06/05/2024 13:02:32

ABBV-383 is a B-cell maturation antigen (BCMA) bispecific antibody T-cell engager being evaluated in relapsed/refractory multip...

analyst-scoreboard-6-ratings-for-abbvie
Analyst Scoreboard: 6 Ratings For AbbVie
06/05/2024 12:01:14

hsbc-upgrades-abbvie-to-buy-announces-185-price-target
HSBC Upgrades AbbVie to Buy, Announces $18...
06/05/2024 10:17:50

HSBC analyst Rajesh Kumar upgrades AbbVie (NYSE:ABBV) from Hold to Buy and announces $185 price target.

abbbie-reports-rinvoq-available-for-pediatric-patients-with-pjia-and-psa
AbbBie Reports RINVOQ Available For Pediat...
06/04/2024 12:32:52

abbvies-options-frenzy-what-you-need-to-know
AbbVie's Options Frenzy: What You Need to ...
06/03/2024 19:30:44

tjx-sysco-lululemon-and-a-healthcare-stock-on-cnbcs-final-trades
TJX, Sysco, Lululemon And A Healthcare Sto...
06/03/2024 12:30:34

Brenda Vingiello of Sand Hill Global Advisors named TJ Maxx's parent company, The TJX Companies Inc., as her final trade.

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/31/2024 17:35:21

chmp-backs-abbvies-skyrizi-for-the-treatment-of-adults-with-moderately-to-severely-active-ulcerative-colitis
CHMP Backs AbbVie's SKYRIZI For The Treatm...
05/31/2024 07:03:48

The positive opinion is based on results from two pivotal Phase 3 trials, INSPIRE and COMMAND, that evaluated the efficacy an...

abbvie-presents-tumor-pipeline-at-asco-2024-with-new-data-from-its-innovative-antibody-drug-conjugate-platform
AbbVie Presents Tumor Pipeline At ASCO 202...
05/28/2024 12:03:48

New safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of A...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/24/2024 17:35:24

after-unitedhealth-cyberattack-drug-distributor-cencora-notifies-americans-health-information-stolen-in-data-breach-in-february
After UnitedHealth Cyberattack, Drug Distr...
05/24/2024 16:00:24

Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnose...

8-health-care-stocks-whale-activity-in-todays-session
8 Health Care Stocks Whale Activity In Tod...
05/23/2024 17:35:21

this-is-what-whales-are-betting-on-abbvie
This Is What Whales Are Betting On AbbVie
05/22/2024 16:31:13

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION